Medicare Enrolled
Dr. Abram Trevino, MD
Internal Medicine · New Braunfels, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Trevino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trevino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Trevino
Dr. Abram Trevino is an internal medicine specialist in New Braunfels, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Trevino performed 35,904 Medicare services across 3,421 unique beneficiaries.
Between the years covered by Open Payments, Dr. Trevino received a total of $6,678 from 50 pharmaceutical and/or device companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Trevino is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in TX
$6,678 industry payments
Medicare Practice Summary
Medicare Utilization ↗35,904
Medicare services
Top 1% in TX for internal medicine
3,421
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,890 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 9,858 | $0 | $3 |
| Iron sucrose injection (Venofer) | 8,500 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 6,300 | $0 | $5 |
| Comprehensive metabolic blood panel | 1,216 | $10 | $64 |
| Complete blood count (CBC) with differential | 1,181 | $8 | $36 |
| Blood draw (venipuncture) | 1,179 | $8 | $20 |
| Dexamethasone injection (steroid) | 844 | $0 | $1 |
| Office visit, established patient (30-39 min) | 680 | $89 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 670 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 520 | $1 | $114 |
| Ferritin level test (iron stores) | 308 | $13 | $60 |
| Iron level test | 306 | $6 | $27 |
| Iron binding capacity test | 306 | $9 | $35 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 274 | $272 | $2,762 |
| Office visit, established patient, complex (40-54 min) | 271 | $129 | $496 |
| Office visit, established patient (20-29 min) | 247 | $60 | $250 |
| Immunoglobulin level test | 225 | $9 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 221 | $22 | $157 |
| Measurement of immunoglobulin light chains | 210 | $17 | $60 |
| Lactate dehydrogenase (enzyme) level | 208 | $6 | $31 |
| Administration of chemotherapy into vein, 1 hour or less | 186 | $98 | $707 |
| Injection, zoledronic acid, 1 mg | 166 | $6 | $431 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 159 | $54 | $211 |
| PSA test (prostate cancer screening) | 112 | $18 | $94 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 105 | $20 | $128 |
| Drug injection, under skin or into muscle | 99 | $10 | $96 |
| Ct scan of chest with contrast | 94 | $45 | $821 |
| CT scan of abdomen and pelvis with contrast | 89 | $164 | $1,067 |
| Administration of additional new drug or substance into vein, 1 hour or less | 88 | $48 | $344 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 82 | $178 | $700 |
| Microscopic examination for white blood cells with manual cell count | 79 | $4 | $22 |
| Complete blood count (CBC), automated | 79 | $6 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 78 | $46 | $313 |
| Vitamin B-12 level test | 75 | $15 | $76 |
| Folic acid level test | 67 | $14 | $73 |
| Reticulated (young) platelet measurement | 63 | $35 | $143 |
| Testosterone (hormone) level, total | 58 | $25 | $143 |
| Administration of chemotherapy into vein, each additional hour | 58 | $21 | $161 |
| Carcinoembryonic antigen (cea) protein level | 55 | $19 | $99 |
| Red blood count automated, with additional calculations | 53 | $5 | $26 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 51 | $15 | $100 |
| Prothrombin time test (blood clotting) | 49 | $4 | $30 |
| Thyroid stimulating hormone (TSH) test | 47 | $16 | $80 |
| Injection, diphenhydramine hcl, up to 50 mg | 42 | $1 | $7 |
| New patient office visit, complex (60-74 min) | 40 | $165 | $709 |
| CT scan of chest, without contrast | 33 | $40 | $686 |
| Sed rate test (inflammation marker) | 33 | $3 | $36 |
| C-reactive protein test (inflammation marker) | 32 | $5 | $33 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 30 | $23 | $145 |
| Unclassified drugs | 29 | $1 | $8 |
| Haptoglobin (serum protein) level | 26 | $12 | $66 |
| Protein measurement, serum | 24 | $11 | $99 |
| Ct scan of abdomen and pelvis without contrast | 23 | $76 | $560 |
| Immunologic analysis technique on serum (immunofixation) | 22 | $22 | $160 |
| Irrigation of implanted venous access drug delivery device | 21 | $19 | $114 |
| Injection of additional new drug or substance into vein | 18 | $12 | $108 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 15 | $91 | $657 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
77.3% medium
21.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,678
Total received (2018-2024)
Avg $954/year across 7 years
Top 13% in TX for internal medicine
50
Companies
467
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,431 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$246 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$48
2023
$121
2022
$66
2021
$140
2020
$428
2019
$2,782
2018
$3,093
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$897
Novartis Pharmaceuticals Corporation
$781
Janssen Biotech, Inc.
$534
Merck Sharp & Dohme Corporation
$452
Eisai Inc.
$422
Genentech USA, Inc.
$420
PFIZER INC.
$407
Janssen Pharmaceuticals, Inc
$208
Lilly USA, LLC
$205
Incyte Corporation
$189
GENZYME CORPORATION
$180
Bayer HealthCare Pharmaceuticals Inc.
$177
Amgen Inc.
$171
Astellas Pharma US Inc
$148
EISAI INC.
$136
Seattle Genetics, Inc.
$115
AbbVie, Inc.
$114
Takeda Pharmaceuticals U.S.A., Inc.
$100
Alexion Pharmaceuticals, Inc.
$89
Pharmacyclics LLC, An AbbVie Company
$87
Gilead Sciences, Inc.
$73
Puma Biotechnology, Inc.
$53
Dendreon Pharmaceuticals LLC
$52
Celgene Corporation
$52
EMD Serono, Inc.
$50
AstraZeneca Pharmaceuticals LP
$47
GlaxoSmithKline, LLC.
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Ipsen Biopharmaceuticals, Inc
$32
AMAG Pharmaceuticals, Inc.
$29
Array BioPharma Inc.
$28
Octapharma USA, Inc.
$27
Sandoz Inc.
$27
Taiho Oncology, Inc.
$22
Kyowa Kirin, Inc.
$22
Dova Pharmaceuticals
$21
Helsinn Therapeutics (U.S.), Inc.
$20
Karyopharm Therapeutics Inc.
$20
Verastem, Inc.
$19
Teva Pharmaceuticals USA, Inc.
$18
Blueprint Medicines Corporation
$18
ADC Therapeutics America, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$16
Kite Pharma, Inc.
$16
Seagen Inc.
$15
ARRAY BIOPHARMA INC
$14
JAZZ PHARMACEUTICALS INC.
$13
TerSera Therapeutics LLC
$13
Rigel Pharmaceuticals, Inc.
$13
Acrotech Biopharma LLC
$12
Top 3 companies account for 33.1% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · Balversa · Bavencio · Braftovi · CALQUENCE · CHANTIX · CYRAMZA · Copiktra · DARZALEX · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ERBITUX · Erivedge · Erleada · FARESTON · FERAHEME · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · Lenvima · Lonsurf · MEKINIST · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · OPDIVO · PROMACTA · PROVENGE · Perjeta · Pomalyst · REBLOZYL · RYDAPT · Reblozyl · Rituxan Hycela · SANCUSO · SCEMBLIX · SOLIRIS · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TASIGNA · TECENTRIQ · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · ULTOMIRIS · VENCLEXTA · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · WILATE · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · ZARXIO · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $19 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
115
Per 100K population
64.5
County median income
$93,776
Nearest hospital
RESOLUTE HEALTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Trevino is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 13% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Trevino experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Trevino performed 9,858 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Trevino receive payments from pharmaceutical companies?
Yes. Dr. Trevino received a total of $6,678 from 50 companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trevino's costs compare to other internal medicine physicians in New Braunfels?
Dr. Trevino's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trevino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in New Braunfels
Browse internal medicine physicians in New Braunfels ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology